BASEL MEDICAL GROUP LTD (BMGL) Stock Income Statement
NASDAQ:BMGL • VGG0864B1031
Current stock price
0.58 USD
+0.02 (+3.57%)
Last:
| 2025 (2025-6-30) | 2024 (2024-6-30) | 2023 (2023-6-30) | 2022 (2022-6-30) | ||||
|---|---|---|---|---|---|---|---|
| Revenue | 11.32M | 10.05M | 9.70M | 10.66M | |||
| Minority Interest Expense | 500.00 | N/A | N/A | N/A | |||
| Operating Expenses | 11.02M | 5.63M | 5.41M | 6.33M | |||
| Selling, General, and Administrative Expenses | 6.54M | 3.59M | 3.27M | 4.04M | |||
| Operating Income | 299.60K | 4.42M | 4.29M | 4.33M | |||
| Interest Income/Expense | -122.60K | -176.20K | 57.00K | -74.20K | |||
| Other Income/Expense | -881.30K | -1.84M | -2.22M | -1.87M | |||
| Non Recurring Items | -10.35M | N/A | N/A | N/A | |||
| Income Before Taxes | -11.05M | 2.40M | 2.13M | 2.39M | |||
| Income Tax | -417.40K | 331.80K | 348.30K | 408.50K | |||
| Net Income | -10.64M | 2.07M | 1.78M | 1.98M | |||
| EBITDA | 1.48M | 4.95M | 4.85M | 4.91M | |||
| Per Share Data | |||||||
| EPS Diluted Total Ops | -0.57 | 0.11 | 0.10 | 0.11 | |||
| Statistics | |||||||
| Profit Margin | -93.96% | 20.62% | 18.38% | 18.56% | |||
| Operating Profit Margin | 2.65% | 44.01% | 44.27% | 40.65% | |||
All data in SGD